Profile data is unavailable for this security.
About the company
Lobe Sciences Ltd. is a Canada-based biopharmaceutical company focused on developing medicines to treat diseases with unmet medical needs. The Company, through collaborations with partners, is engaged in research and development focused on treating chronic cluster headache (an orphan disease), refractive anxiety, and sickle cell disease. In addition, the Company is commercializing Altemia, for the treatment of patients diagnosed with Sickle Cell Disease. The Company is engaged in Phase 1 and Phase 2 activities in its drug portfolios. Its subsidiaries include Eleusian Biosciences Corp., Lobe Sciences Australia Pty Ltd., and Altemia & Company, LLC.
- Revenue in CAD (TTM)976.74k
- Net income in CAD-2.97m
- Incorporated2010
- Employees--
- LocationLobe Sciences Ltd1400-1199 West Hastings StreetVANCOUVER V6E 3T5CanadaCAN
- Phone+1 (604) 834-9499
- Fax+1 (604) 628-1249
- Websitehttps://www.lobesciences.com/
More ▼